Industry News
Pharmaceutical Industry News
Did BMS set up a subsidiary to avoid paying $1.4B in US taxes? The Senate finance chairman is on the case
Did BMS set up a subsidiary to avoid paying $1.4B in US taxes? The Senate finance chairman is on the case esagonowsky Wed, 01/19/2022 - 09:41
As Pfizer’s Cibinqo grabs an FDA green light, JAK inhibitors’ entry into the eczema market ‘has split doctors’ opinion: report
As Pfizer's Cibinqo grabs an FDA green light, JAK inhibitors' entry into the eczema market 'has split doctors' opinion: report badams Wed, 01/19/2022 - 08:11
Apprentice.io scores $100M funding for augmented reality tech that helped drug plants work through COVID-time
Apprentice.io scores $100M funding for augmented reality tech that helped drug plants work through COVID-time kdunleavy Wed, 01/19/2022 - 00:04
Fierce JPM Week: Despite pandemic’s challenges, collaboration in biopharma is ‘alive and well,’ panel says
Fierce JPM Week: Despite pandemic's challenges, collaboration in biopharma is 'alive and well,' panel says esagonowsky Tue, 01/18/2022 - 14:40
AstraZeneca climbs a Himalaya to find ill-fated treme a place alongside Imfinzi in liver cancer
AstraZeneca climbs a Himalaya to find ill-fated treme a place alongside Imfinzi in liver cancer aliu Tue, 01/18/2022 - 13:18
Merck’s Keytruda narrowly passes liver cancer confirmatory trial, but murky FDA fate lies ahead
Merck's Keytruda narrowly passes liver cancer confirmatory trial, but murky FDA fate lies ahead aliu Tue, 01/18/2022 - 11:40
FDA extends decision dates on bluebird bio’s gene therapy drugs beti-cel and eli-cel by 3 months
FDA extends decision dates on bluebird bio's gene therapy drugs beti-cel and eli-cel by 3 months kdunleavy Tue, 01/18/2022 - 11:15
The wait is over: AbbVie’s Rinvoq chalks up FDA win with favorable atopic dermatitis label
The wait is over: AbbVie's Rinvoq chalks up FDA win with favorable atopic dermatitis label aliu Tue, 01/18/2022 - 10:44
Inside the Catalent FDA citation said to trigger Novo Nordisk’s Wegovy supply hiccup
Inside the Catalent FDA citation said to trigger Novo Nordisk's Wegovy supply hiccup fkansteiner Tue, 01/18/2022 - 09:39
Hikma shells out $45.75M to buy bankrupt Teligent’s Canadian assets
Hikma shells out $45.75M to buy bankrupt Teligent's Canadian assets jkeenan Tue, 01/18/2022 - 09:27
Chasing Pfizer, Antares advances rescue med into pivotal trial
Chasing Pfizer, Antares advances rescue med into pivotal trial ntaylor Tue, 01/18/2022 - 08:33
Ori Biotech reaps $100M in series B round to help launch innovative cell manufacturing tech
Ori Biotech reaps $100M in series B round to help launch innovative cell manufacturing tech jkeenan Tue, 01/18/2022 - 08:28
Fierce JPM Week: 5 industry execs discuss pandemic supply chain issues, solutions
Fierce JPM Week: 5 industry execs discuss pandemic supply chain issues, solutions kdunleavy Tue, 01/18/2022 - 06:46
GlaxoSmithKline rejects Unilever’s $68B consumer health buyout offer, but a bigger bid is brewing
GlaxoSmithKline rejects Unilever's $68B consumer health buyout offer, but a bigger bid is brewing aliu Tue, 01/18/2022 - 06:27
GSK, Vir file for emergency FDA authorization of intramuscular formulation of COVID-19 antibody
GSK, Vir file for emergency FDA authorization of intramuscular formulation of COVID-19 antibody ntaylor Tue, 01/18/2022 - 06:04
Journey of Vyne’s topical drugs continues with $20M deal
Journey of Vyne's topical drugs continues with $20M deal ntaylor Tue, 01/18/2022 - 06:01
Stanford spinout forms drug delivery joint venture with Chinese biotech
Stanford spinout forms drug delivery joint venture with Chinese biotech ntaylor Tue, 01/18/2022 - 05:57
Daiichi Sankyo, with tighter focus on oncology, sells 8 aging US cardiovascular drugs to diversifying Cosette
Daiichi Sankyo, with tighter focus on oncology, sells 8 aging US cardiovascular drugs to diversifying Cosette kdunleavy Mon, 01/17/2022 - 21:43
Unilever Pursues Glaxo and Pfizer Consumer Health Venture
Rejected three times, Unilever suggests it will keep fighting to acquire a giant in the world of pain relievers, toothpastes and cold treatments.
Howard Solomon, 94, Dies; His Business Success Had a Personal Connection
After one of his sons fell into a deep depression, he helped him recover. He later licensed an antidepressant that was a boon to his pharmaceutical company.